SCHEMBL14928306

SCHEMBL14928306

CCCOc1ncc(N)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3378270 0.85 TSHR (0.38) KDM4EALDH1A1MAPTMEN1TP53
SCHEMBL14910166 0.84 TSHR (0.40) MEN1KMT2ANOS3NOS1NOS2
SCHEMBL14928594 0.80 ALDH1A1 (0.39) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL3375412 0.80 CSNK2A1 (0.39) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL323074 0.76 MAPT (0.42) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL19055601 0.75 AGBL2 (0.44) ALDH1A1MEN1GAAKMT2ALMNA
SCHEMBL14928601 0.75 TRPC6 (0.36) KDM4EALDH1A1MAPTHTTMEN1
Hydrochloric Acid SCHEMBL114703 0.75 MAPT (0.41) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL1033025 0.74 BCHE (0.41) MAPTHTTMEN1KMT2AHSD17B10
SCHEMBL2956640 0.74 NOS3 (0.39) KDM4EALDH1A1MAPTHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK KDM4E 2420/4885ALDH1A1 1638/4885MAPT 4186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.